Biobanking.com

Emulate Inc., has secured a $36 million Series C financing round led by Founders Fund. With the financing transaction, Aaron VanDevender, Chief Scientist and Principal at Founders Fund, joins Emulate’s board of directors. Founders Fund is a leading Bay Area...

Founded in 2016, the company AcuraStem is led by an exceptional team of PhDs, professors, technology entrepreneurs, and successful drug company veterans utilizing the latest scientific breakthroughs to first address one of the most challenging, but tractable diseases, amyotrophic...

Circulating cell-free tumor DNA (cfDNA) is released by solid tumors into the blood stream. There is a lot of interest among the medical and biobanking communities in using cfDNA as a relatively non-invasive way of predicting cancer prognosis and...

Focused on accelerating discovery, CoreBiome is a microbiome genomics company unleashing the translational potential of the microbiome. Core customers are in the pharmaceutical, agriculture, and research communities. Fast and information-rich characterizations of microbial diversity and function are provided by...

The National Cancer Research Institute (NCRI) was established in 2001 with a mission to bring together all the key players in cancer research in the UK to identify where research was most needed and where it was most likely...

The UK Biobank is one of the biggest biobanking projects in the world with samples and data from over 500,000 participants aged 40 to 69 years. UK Biobank participants allow doctors to take repeat physiological measurements such as blood...

The University of Arizona (UA) Health Sciences includes the UA Colleges of Medicine (Phoenix and Tucson), Nursing, Pharmacy and Mel and Enid Zuckerman College of Public Health, with main campus locations in Tucson and the growing Phoenix Biomedical Campus...

ATCC (American Type Culture Collection) is a global biological materials resource and standards organization whose mission focusses on the acquisition, authentication, production, preservation, development, and distribution of standard reference microorganisms, cell lines, and other materials. ATCC also develops high...

Scientists around the world are searching for reliable biomarkers to diagnose diseases and track disease progression and patients’ responses to treatment. There has been a lot of excitement about the potential for circulating microRNAs to be biomarkers for a...

Caladrius Biosciences, Inc. is a clinical stage biopharmaceutical company with multiple technology platforms including cell therapies targeting select cardiovascular indications and autoimmune diseases. Invetech Pty Ltd., is a full-service provider of product design, instrument development and contract manufacturing with a...